Article Information
- Received May 9, 2004
- Revision received September 17, 2004
- Accepted September 18, 2004
- First published November 3, 2004.
- Version of record published November 3, 2004.
Author Information
- 1Department of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine, Molecular Biology Institute, University of California, Los Angeles, California 90095, and 2Departments of Ophthalmology and Vision Sciences and Molecular Biology and Pharmacology, Washington University School of Medicine in St. Louis, St. Louis, Missouri 63110
Author contributions
Disclosures
- Received May 9, 2004.
- Revision received September 17, 2004.
- Accepted September 18, 2004.
This work is supported by grants from the Research to Prevent Blindness Foundation, March of Dimes Birth Defects Foundation, Karl Kirchgessner Foundation, and National Eye Institute (EY12270, EY01444) to X.-J.Y. S.C. is supported by Research to Prevent Blindness and the National Eye Institute (EY12543). O.G. was supported in part by Institut National de la Santé et de la Recherche Médicale (France) and a North Atlantic Treaty Organization Travel Fellowship. K.D.R. is supported by National Eye Institute training Grant T32 EY07026. We thank Ke Shuai and Robert Molday for gifts of antibodies.
Correspondence should be addressed to Xian-Jie Yang, Jules Stein Eye Institute, University of California Los Angeles School of Medicine, 100 Stein Plaza, Los Angeles, CA 90095. E-mail: yang{at}jsei.ucla.edu.
O. Goureau's present address: Laboratoire de Physiopathologie Cellulaire et Moléculaire de la Rétine, Institut National de la Santé et de la Recherche Médicale U592, Hôpital Saint-Antoine, 75571 Paris cedex 12, France.
Copyright © 2004 Society for Neuroscience 0270-6474/04/249779-10$15.00/0
Online Impact